Table Filtering
Submissions
GlyTouCan
Glycan Structure Repository
GlyComb
Glycoconjugate Repository
GlycoPOST
Glycomics MS raw data Repository
UniCarb-DR
Glycomics MS Repository for glycan annotations from GlycoWorkbench
All Resources
Genes / Proteins / Lipids Glycans / Glycoconjugates Glycomes Pathways / Interactions / Diseases / Organisms
DisGeNET
DisGeNET is a knowledge management platform that integrates and standardizes the data of genes and mutations related to diseases from multiple sources. It covers entire range of human disease.
| Source | Last Updated |
|---|---|
| DisGeNET | July 29, 2024 |
| Disease ID | Disease Name | Gene Symbol | Gene ID | Gene Name | UniProt ID ▲ |
|---|---|---|---|---|---|
| C0206641 | Osteochondromatosis | HSPG2 | 3339 | heparan sulfate proteoglycan 2 | P98160 |
| C0011854 | Diabetes Mellitus, Insulin-Dependent | HSPG2 | 3339 | heparan sulfate proteoglycan 2 | P98160 |
| C2239176 | Liver carcinoma | HSPG2 | 3339 | heparan sulfate proteoglycan 2 | P98160 |
| C0011849 | Diabetes Mellitus | HSPG2 | 3339 | heparan sulfate proteoglycan 2 | P98160 |
| C1857100 | Dyssegmental dysplasia | HSPG2 | 3339 | heparan sulfate proteoglycan 2 | P98160 |
| C0023903 | Liver neoplasms | HSPG2 | 3339 | heparan sulfate proteoglycan 2 | P98160 |
| C0006826 | Malignant Neoplasms | HSPG2 | 3339 | heparan sulfate proteoglycan 2 | P98160 |
| C0409974 | Lupus Erythematosus | HSPG2 | 3339 | heparan sulfate proteoglycan 2 | P98160 |
| C4552003 | EHLERS-DANLOS SYNDROME, SPONDYLODYSPLASTIC TYPE, 1 | HSPG2 | 3339 | heparan sulfate proteoglycan 2 | P98160 |
| C0278878 | Adult Glioblastoma | HSPG2 | 3339 | heparan sulfate proteoglycan 2 | P98160 |
| C4721610 | Carcinoma, Ovarian Epithelial | HSPG2 | 3339 | heparan sulfate proteoglycan 2 | P98160 |
| C0017638 | Glioma | HSPG2 | 3339 | heparan sulfate proteoglycan 2 | P98160 |
| C0036391 | Schwartz-Jampel Syndrome | HSPG2 | 3339 | heparan sulfate proteoglycan 2 | P98160 |
| C0029456 | Osteoporosis | HSPG2 | 3339 | heparan sulfate proteoglycan 2 | P98160 |
| C0013264 | Muscular Dystrophy, Duchenne | HSPG2 | 3339 | heparan sulfate proteoglycan 2 | P98160 |
| C1834674 | BETHLEM MYOPATHY 1 | HSPG2 | 3339 | heparan sulfate proteoglycan 2 | P98160 |
| C0019163 | Hepatitis B | HSPG2 | 3339 | heparan sulfate proteoglycan 2 | P98160 |
| C0027651 | Neoplasms | HSPG2 | 3339 | heparan sulfate proteoglycan 2 | P98160 |
| C1868678 | THANATOPHORIC DYSPLASIA, TYPE I (disorder) | HSPG2 | 3339 | heparan sulfate proteoglycan 2 | P98160 |
| C0014527 | Epidermolysis Bullosa | HSPG2 | 3339 | heparan sulfate proteoglycan 2 | P98160 |
| C3501848 | Nephrosis, congenital | HSPG2 | 3339 | heparan sulfate proteoglycan 2 | P98160 |
| C0003850 | Arteriosclerosis | HSPG2 | 3339 | heparan sulfate proteoglycan 2 | P98160 |
| C0279000 | Liver and Intrahepatic Biliary Tract Carcinoma | HSPG2 | 3339 | heparan sulfate proteoglycan 2 | P98160 |
| C0038325 | Stevens-Johnson Syndrome | HSPG2 | 3339 | heparan sulfate proteoglycan 2 | P98160 |
| C0010674 | Cystic Fibrosis | HSPG2 | 3339 | heparan sulfate proteoglycan 2 | P98160 |
